HER2-specific immunoligands engaging NKp30 or NKp80 trigger NK-cell-mediated lysis of tumor cells and enhance antibodydependent cell-mediated cytotoxicity

Matthias Peipp, Stefanie Derer, Stefan Lohse, Matthias Staudinger, Katja Klausz, Thomas Valerius, Martin Gramatzki, Christian Kellner*

*Corresponding author for this work
13 Citations (Scopus)

Fingerprint

Dive into the research topics of 'HER2-specific immunoligands engaging NKp30 or NKp80 trigger NK-cell-mediated lysis of tumor cells and enhance antibodydependent cell-mediated cytotoxicity'. Together they form a unique fingerprint.

Medicine & Life Sciences